[Translation] A Phase I Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Cendakimab in Healthy Chinese Subjects
主要目的:在中国健康受试者中评估Cendakimab 皮下给药的药代动力学;
次要目的:在中国健康受试者中评估Cendakimab 皮下给药的安全性和耐受性;
探索性目的(用于支持药物注册上市申请):在中国健康受试者中评估Cendakimab皮下给药的免疫原性
[Translation] Primary objective: To evaluate the pharmacokinetics of subcutaneous cendakimab in healthy Chinese subjects;
Secondary objective: To evaluate the safety and tolerability of subcutaneous cendakimab in healthy Chinese subjects;
Exploratory objective (to support drug registration and marketing application): To evaluate the immunogenicity of subcutaneous cendakimab in healthy Chinese subjects